Literature DB >> 11877357

Change in diastolic left ventricular filling after one year of antihypertensive treatment: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study.

Kristian Wachtell1, Jonathan N Bella, Jens Rokkedal, Vittorio Palmieri, Vasilios Papademetriou, Björn Dahlöf, Tapio Aalto, Eva Gerdts, Richard B Devereux.   

Abstract

BACKGROUND: It is well established that hypertensive patients with left ventricular (LV) hypertrophy have impaired diastolic filling. However, the impact of antihypertensive treatment and LV mass reduction on LV diastolic filling remains unclear. METHODS AND
RESULTS: Echocardiograms were recorded in 728 hypertensive patients with ECG-verified LV hypertrophy (Cornell voltage-duration or Sokolow-Lyon) at baseline and after 1 year of blinded treatment with either losartan or atenolol-based regimen. Systolic and diastolic blood pressures (BP) were reduced on average 23/11 mm Hg; isovolumic relaxation time and E/A ratio became more normal, and LV inflow deceleration time prolonged (all P<0.001). Directionally opposite changes in isovolumic relaxation time (IVRT) and deceleration time indicate improvement in active LV relaxation and passive chamber stiffness during early diastole. Prevalences of normal LV filling increased, abnormal relaxation and pseudonormalization decreased, and restrictive filling pattern remained unchanged (P<0.05). Patients with reduction in LV mass had smaller left atrial diameter, shortened IVRT, increased E/A ratio, and prolonged LV inflow deceleration time (all P<0.001). Patients without LV mass reduction had no change in diastolic filling parameters (P=NS). IVRT shortening was independently associated with reduction in LV mass. Increase in E/A ratio was independently associated with reduction in diastolic BP, and increase in the deceleration time was independently associated with reduced end-systolic relative wall thickness.
CONCLUSIONS: Antihypertensive therapy resulting in LV mass or relative wall thickness regression is associated with significant improvement of diastolic filling parameters related to active relaxation and passive chamber stiffness compared with patients without regression, independent of BP reduction; however, abnormalities of diastolic LV filling remain common.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11877357     DOI: 10.1161/hc0902.104599

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  42 in total

Review 1.  Regression of left ventricular hypertrophy is a key goal of hypertension management.

Authors:  Rubin Zhang; Judy Crump; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2003-08       Impact factor: 5.369

Review 2.  [Drug treatment of chronic heart failure].

Authors:  M Böhm; N Werner; M Kindermann
Journal:  Clin Res Cardiol       Date:  2006       Impact factor: 5.460

Review 3.  Therapeutic approaches to diastolic dysfunction.

Authors:  Rajesh Janardhanan; Akshay S Desai; Scott D Solomon
Journal:  Curr Hypertens Rep       Date:  2009-08       Impact factor: 5.369

4.  Aging and the brain renin-angiotensin system: relevance to age-related decline in cardiac function.

Authors:  Debra I Diz; Jasmina Varagic; Leanne Groban
Journal:  Future Cardiol       Date:  2008-05

5.  [New therapy concepts for heart failure with preserved ejection fraction].

Authors:  C Tschöpe; B Pieske
Journal:  Herz       Date:  2015-04       Impact factor: 1.443

6.  Pleiotropic effects of the acute and chronic inhibition of the renin-angiotensin system in hypertensives.

Authors:  K Stamatelopoulos; D Bramos; E Manios; E Alexaki; A Kaladaridou; G Georgiopoulos; E Koroboki; A Kolyviras; K Stellos; N Zakopoulos; S Toumanidis
Journal:  J Hum Hypertens       Date:  2013-11-28       Impact factor: 3.012

Review 7.  Pathways involved in the transition from hypertension to hypertrophy to heart failure. Treatment strategies.

Authors:  John W Wright; Shigehiko Mizutani; Joseph W Harding
Journal:  Heart Fail Rev       Date:  2007-11-07       Impact factor: 4.214

8.  Successful treatment of hypertension accounts for improvements in markers of diastolic function - a pilot study comparing hydrochlorothiazide-based and amlodipine-based treatment strategies.

Authors:  Kofo O Ogunyankin; Andrew G Day
Journal:  Can J Cardiol       Date:  2009-12       Impact factor: 5.223

9.  Left Ventricular Diastolic Function in Nigerian Patients with Essential Hypertension: A Retrospective Study to Compare Angiotensin Converting Enzyme Inhibitors, Calcium Channel Blockade or Their Combination.

Authors:  Olufemi E Ajayi; Anthony O Akintomide; Adegboyega Q Adigun; Adesuyi A L Ajayi
Journal:  Arch Drug Inf       Date:  2008-07

10.  Regression of hypertensive nephropathy during three years of optimal blood pressure control.

Authors:  Heidi Puttinger; Afschin Soleiman; Rainer Oberbauer
Journal:  Wien Klin Wochenschr       Date:  2003-07-15       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.